| 000 | 05493cam a2200469Ii 4500 | ||
|---|---|---|---|
| 001 | 95847 | ||
| 003 | ES-MaUEC | ||
| 005 | 20230102112724.0 | ||
| 006 | m o d | ||
| 007 | cr cnu---unuuu | ||
| 008 | 170424t20172017sz a ob 001 0 eng d | ||
| 020 |
_a3319526693 _q(electronic bk.) |
||
| 020 |
_a9783319526690 _q(electronic bk.) |
||
| 020 | _z3319526650 | ||
| 020 | _z3319526685 | ||
| 020 | _z9783319526652 | ||
| 020 | _z9783319526683 | ||
| 040 |
_aN$T _cN$T _dGW5XE _dEBLCP _dYDX _dAZU _dUPM _dOCLCF _dUAB _dESU _dVT2 _dIOG _dMERER _dOCLCQ _dU3W _dES-MaUEC _bspa |
||
| 050 | 4 |
_aQR53 _b.M537 2017 EB |
|
| 245 | 0 | 0 |
_aMicrobial applications. _nVol. 2, _pBiomedicine, agriculture and industry _cVipin Chandra Kalia, editors. |
| 246 | 3 | _aBiomedicine, agriculture and industry | |
| 264 | 1 |
_aCham, Switzerland _bSpringer _c[2017] |
|
| 264 | 4 | _c2017 | |
| 300 |
_a1 recurso en línea _bilustraciones |
||
| 336 |
_aTexto _btxt _2rdacontent |
||
| 337 |
_aelectrónico _bc _2rdamedia |
||
| 338 |
_arecurso electrónico _bcr _2rdacarrier |
||
| 347 |
_atext file _bPDF _2rda |
||
| 500 |
_aSpringerLink _bSpringer Biomedical and Life Sciences eBooks 2017 English+International |
||
| 504 | _aIncluye referencias bibliográficas | ||
| 505 | 0 | _aPreface; Contents; About the Editor; Part I: Biomedicine; Role of Bacteria in Nanocompound Formation and Their Application in Medical; 1 Introduction; 2 Role of Bacteria in Nanocompound Formation; 2.1 Intracellular Biosynthesis; 2.2 Extracellular Biosynthesis; 2.3 Synthesis of Metal Nanocompounds; 2.3.1 Synthesis of Silver NPs (AgNPs); 2.3.2 Synthesis of Gold NPs (AuNPs); 2.3.3 Synthesis of Copper NPs (CuNPs); 2.3.4 Synthesis of Magnetic NPs (MNPs); 2.3.5 Synthesis of Quantum Dots (QDs); 3 Factors Affecting NP Synthesis by Microbes; 3.1 Age and Concentration of the Microbial Cell Culture. | |
| 505 | 8 | _a3 Biomedical Application of Compounds Isolated from Marine Actinobacteria3.1 Cancer; 3.2 Antibacterial and Antifungal; 3.3 Antimalaria, Anti-inflammatory, Antifouling, etc.; 4 Conclusion and Future Perspectives; References; Antimycobacterial Agents: To Target or Not to Target; 1 Introduction; 2 Existing Treatment Regime; 2.1 Drug-Sensitive TB; 2.2 Multidrug-Resistant (MDR) TB; 2.3 Extremely Drug-Resistant (XDR) and Totally Drug-Resistant (TDR) TB; 3 Mechanism of Action; 3.1 First-Line Drugs; 3.1.1 Isoniazid; 3.1.2 Rifampicin; 3.1.3 Ethambutol; 3.1.4 Streptomycin; 3.1.5 Pyrazinamide. | |
| 505 | 8 | _a3.2 Concentration of Metal Salt/Substrate Used3.3 pH; 3.4 Temperature; 3.5 Incubation Time; 4 Mechanism of Nanocompound Formation by Microbes; 4.1 Mechanism for the Synthesis of AgNPs by Bacteria; 4.2 Mechanism of Synthesis of AuNPs by Microbes; 4.3 Mechanistic Action of Microbial Synthesis of CuNPs; 4.4 Mechanism of MNPs; 4.5 Mechanism of Synthesis of Quantum Dots; 5 Multi-scale Characterization of Nanocompounds; 5.1 Scanning Electron Microscope (SEM); 5.2 Transmission Electron Microscope (TEM); 5.3 Atomic Force Microscope (AFM); 5.4 Dynamic Light Scattering (DLS); 5.5 UV-Vis Spectroscopy. | |
| 505 | 8 | _a4.1 Association of Melatonin with Cancer4.2 Antibacterial Property of Melatonin; 4.3 Antifungal Property of Melatonin; 4.4 Melatonin in Reproduction; 4.5 Antiviral Activity of Melatonin; 5 Conclusion; References; Major Source of Marine Actinobacteria and Its Biomedical Application; 1 Introduction; 1.1 Actinobacteria; 2 Actinobacteria Associated with Marine Flora and Fauna; 2.1 Actinobacteria Associated with Marine Flora; 2.1.1 Mangroves, Seagrasses, and Seaweeds; 2.2 Marine Fauna; 2.2.1 Ascidians and Mollusks; 2.2.2 Corals, Sponges, and Fish. | |
| 505 | 8 | _a5.6 Fourier Transform Infrared Spectroscopy (FTIR)6 Medical Applications of Nanocompounds; 6.1 Antimicrobial Activity; 6.2 Imaging for Diagnostics; 6.2.1 Imaging for Disease Diagnostics; 6.2.2 Imaging for Cancer Detection; 6.3 Therapy; 6.3.1 Cancer Treatment; 6.3.2 Disease Treatment; 6.3.3 Radiotherapy; 6.4 Theranostics; 7 Conclusions; 8 Future Perspectives; References; Microbial Source of Melatonin and Its Clinical Aspects; 1 Introduction; 2 Melatonin Production in Different Microorganisms; 3 Synthesis and Regulation of Melatonin; 4 Functions of Melatonin. | |
| 520 | 3 | _aThis contributed volume provides insights into multiple applications using microbes to promote productivity in agriculture, to produce biochemicals or to respond to challenges in biomedicine. It highlights the microbial production of nanocompounds with medical functionality alongside new anti-mycobacterial strategies, and introduces plant-growth-promoting Rhizobacteria as well as the correlation between biofilm formation and crop productivity. Further, the authors illustrate the green synthesis of biochemical compounds, such as hydroxamid acid or biosurfactants, using microbial and fungal enzymes. It inspires young researchers and experienced scientists in the field of microbiology to explore the combined use of green, white and red biotechnology for industrial purposes, which will be one of the central topics for future generations. | |
| 650 | 7 |
_aMicrobiología industrial _2embne _0(OCoLC)fst01019471 _0 _9138685 |
|
| 700 | 1 |
_aKalia, Vipin Chandra, _eeditor literario _994146 |
|
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=http://link.springer.com/10.1007/978-3-319-52669-0 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 988 | _aEBOOK, asignarmaterias, EBSPRINGER_2017C | ||
| 998 |
_b02/2018 _dz _e- _zSI |
||
| 999 |
_c95847 _d95847 _x1 |
||